Company intelligence / Profile preview

Shenzhen BinDeBio

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

BinDeBio is a clinical-stage biotechnology company headquartered in Shenzhen, China, dedicated to the development of innovative oncolytic virus therapies for cancer. The company utilizes its proprietary OV-iT (Oncolytic Virus-mediated Immunotherapy) platform to engineer viruses that selectively target and destroy tumor cells while stimulating a systemic anti-tumor immune response. Its lead program, BD-001, is an engineered herpes simplex virus type 1 (HSV-1) currently being evaluated in clinical trials for the treatment of advanced solid tumors. BinDeBio aims to address unmet medical needs in oncology by combining viral oncolysis with various immunotherapeutic modalities. The company's pipeline includes several next-generation oncolytic candidates designed to express therapeutic payloads such as cytokines and antibodies.

Therapeutic areas: Oncology
Modalities: Oncolytic virus therapyImmunotherapyGene therapy
Industry: Biotech

Drug pipeline

1 asset

anti-DR5 CAR-T

Preclinical

Beyond the preview

Go deeper on Shenzhen BinDeBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen BinDeBio.

Explore the full profile